05/06/2010 // West Palm Beach, Florida, USA // Nicole Howley // Nicole Howley
Philadelphia, PA—Following the recall of liquid infants’ and children’s medications, the Food and Drug Administration (FDA) has released a report, which cited numerous deficiencies in the production of the recalled drugs. The report, which was released on May 4, 2010, came less than a week after the recall, as reported by CNN.
The report stated that bacteria was found in the McNeil plant, where the medication was produced; although it is too early to tell what type of bacteria was found at the plant. Just a week earlier, 50 over-the-counter medications including Tylenol, Motrin, Zyrtec and Benadryl were recalled, and production was shut down.
The FDA stated, “We want to be certain that consumers discontinue using these products and that they know what to do if they have concerns about a specific product. While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality. We are investigating the products and facilities associated with this recall and will provide updates as we learn more.”
The recall was initiated because the medications did not meet the required quality standards.
The FDA plans to follow up on the corrections and will make a decision on whether or not they should pursue McNeil any further. If McNeil does not comply, the company could face criminal penalties and seizure of its products.
Legal News Reporter: Nicole Howley-Legal news for product liability lawyers.